about
Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis CAutophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.Protein Requirements for Critically Ill Patients With Renal and Liver Failure.Ascites, refractory ascites and hyponatremia in cirrhosis.Adipokines in Liver Cirrhosis.Albumin Prevents Infections in Patients with Chronic Liver Failure in a Single-arm Feasibility Trial.Hepatic stellate cells as key target in liver fibrosis.Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients.Cirrhosis and LI-RADS.African-Americans with Cirrhosis Are Less Likely to Receive Endoscopic Variceal Screening Within One Year of Cirrhosis Diagnosis.Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis.Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis.TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection.Fluid balance concepts in medicine: Principles and practice.Review article: the role of the microcirculation in liver cirrhosis.Circulating fibroblast growth factor 21 in patients with liver cirrhosis.Prognostic impact and risk factors of low body mass index in patients undergoing liver transplantation.Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines.Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients.Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure
P2860
Q33582978-20527F94-B1F2-475A-9129-222106DEE05FQ37544826-CA86D479-EE1C-402F-BA57-5F084953A049Q37593985-38DEADD0-DBCF-42FC-8A7D-EF38727C185AQ38655765-EB0D53FD-A1DE-4D76-9D9A-CEB2391AE9D3Q39139047-BD1F4BF1-DC40-4F2C-81F8-A25371C8E6E5Q39323841-C42884CC-3535-484F-BB12-0387EB7D3F54Q39404643-9E4304A8-2340-4AAC-BB2D-5BA1E84A27CBQ40045308-8B11B771-9383-40E7-9FA0-E0EF97052BB0Q40200602-13A6BAF3-88C6-4072-94D7-C1A338E45F4BQ41042331-FF1D54F6-1632-498E-A2C9-FC89F5EB2E3DQ46270707-F69FFB73-FC42-4311-9051-1624748B9134Q46754211-13489E9C-DF43-4888-B5AE-95295D84D7C5Q47147228-D2B2F2C6-B842-4F48-B175-584AB13E93B1Q47291117-4AFFF678-1BC1-43EB-B130-A80BB4C2CF2EQ47372528-476DA422-1392-4ECD-A8F2-599A48CAB92FQ47563178-20652180-6AEF-42E8-9ECD-9337B84C0D3AQ47705540-55193992-9B67-4D61-BFEF-896168142859Q47812599-B9F1C966-20D0-47FB-B097-D8A0382F438CQ48027127-C5FC70A1-7E66-4144-AE21-5564F83BA8E9Q48175320-AFCDE210-1F8B-4D6C-BC16-9EDE158033D1Q48533165-CD5471A5-9B65-49CD-8CEE-06ABB880D95FQ49305575-4B099BFB-DDA7-44D3-8741-D6F1C446421AQ51743701-7CFD60CE-FA83-447E-BE0D-5719587C5995Q55376294-C2DABE8B-6C47-46AE-82CA-057085323EAFQ57824692-4D9D504E-197E-4157-9DEC-37872ED98DC5
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Treatment of Patients with Cirrhosis.
@en
type
label
Treatment of Patients with Cirrhosis.
@en
prefLabel
Treatment of Patients with Cirrhosis.
@en
P356
P1476
Treatment of Patients with Cirrhosis.
@en
P2093
Bruce A Runyon
Phillip S Ge
P304
P356
10.1056/NEJMRA1504367
P407
P577
2016-08-01T00:00:00Z